http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022155294-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_74b7b50944d8e1960440fb1f5440b7fd |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-6424 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-88 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-12 |
| filingDate | 2022-01-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_268dda993bc4f23a64a4218cbc879abe http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d1cfc26a63494bb3a59102ae2bb6dec7 |
| publicationDate | 2022-07-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-2022155294-A1 |
| titleOfInvention | Macrocycle complement factor b inhibitors |
| abstract | This disclosure relates to compounds, pharmaceutical compositions comprising them, and methods of using the compounds and compositions for treating diseases or disorders related to misregulation of the Complement cascade pathway. More particularly, this disclosure relates to macrocyclic compounds and pharmaceutical compositions thereof, methods of inhibiting Complement Factor B (CFB) expression with these compounds, and methods of treating diseases or disorders mediated by CFB. |
| priorityDate | 2021-01-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 129.